HealthQuill Cardiovascular Events
Research uncovers significant discrepancies in ingredient labels and presence of banned compounds
Health

Rosuvastatin may lower mortality compared to atorvastatin: Study

HQ Team November 9, 2024: A recent study indicates that rosuvastatin is associated with a slightly reduced risk of all-cause mortality and major.

Read More
Danish pharmaceutical company, Novo Nordisk’s oral semaglutide drug to treat type 2 diabetes helped reduce heart diseases by 14% compared to a dummy medicine in a trial, according to a statement.
Drugs Health Pharma

Novo’s type 2 oral diabetic drug cuts heart diseases by 14% in a trial

Danish pharmaceutical company, Novo Nordisk’s oral semaglutide drug to treat type 2 diabetes helped reduce heart diseases by 14% compared to a dummy.

Read More
A simple blood test — done when women are in their 30s — can measure types of proteins in the blood that may shape heart diseases and aid physicians in early detection and treatment in the long run, a study finds.
Drugs Health Pharma

Simple blood tests can map women’s heart disease risks when done early

A simple blood test — done when women are in their 30s — can measure types of proteins in the blood that may.

Read More
Women stand to benefit more than men when they indulge in physical activities as it lowers the risk of premature death or fatal cardiovascular events, according to a study conducted by the US-based National Institutes of Health.
Drugs Health Pharma

Exercises help women more than men, cut risk of premature death

HQ Team February 21, 2024: Women stand to benefit more than men when they indulge in physical activities as it lowers the risk.

Read More